{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:21:10Z","timestamp":1791523270577,"version":"4.3.4"},"reference-count":64,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.2967\/jnumed.119.229054","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T01:55:22Z","timestamp":1569030922000},"page":"70-79","source":"Crossref","is-referenced-by-count":38,"title":["Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes"],"prefix":"10.2967","volume":"61","author":[{"given":"Jos\u00e9","family":"Carlos dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Beijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Bauder-W\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bene\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"2021051712142289000_61.1.70.1","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res."},{"key":"2021051712142289000_61.1.70.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502101102"},{"key":"2021051712142289000_61.1.70.3","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","article-title":"Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem."},{"key":"2021051712142289000_61.1.70.4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/pcan.2016.13","article-title":"PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges","volume":"19","author":"Rowe","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2021051712142289000_61.1.70.5","doi-asserted-by":"publisher","DOI":"10.1021\/bc200279b"},{"key":"2021051712142289000_61.1.70.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147413"},{"key":"2021051712142289000_61.1.70.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.181768"},{"key":"2021051712142289000_61.1.70.8","first-page":"S19","article-title":"ProstaScint\u00ae scan: contemporary use in clinical practice","volume":"6","author":"Taneja","year":"2004","journal-title":"Rev Urol."},{"key":"2021051712142289000_61.1.70.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000095151.97404.7c"},{"key":"2021051712142289000_61.1.70.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0190-7"},{"key":"2021051712142289000_61.1.70.11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2478\/v10019-010-0050-8","article-title":"Role of 18F-choline PET\/CT in evaluation of patients with prostate carcinoma","volume":"45","author":"Hodolic","year":"2011","journal-title":"Radiol Oncol."},{"key":"2021051712142289000_61.1.70.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1357"},{"key":"2021051712142289000_61.1.70.13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/RLU.0000000000001804","article-title":"18F-DCFBC prostate-specific membrane antigen-targeted PET\/CT imaging in localized prostate cancer: correlation with multiparametric MRI and histopathology","volume":"42","author":"Turkbey","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2021051712142289000_61.1.70.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.158550"},{"key":"2021051712142289000_61.1.70.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2713-y"},{"key":"2021051712142289000_61.1.70.16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/pros.23444","article-title":"99mTc-MIP-1404-SPECT\/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer","volume":"78","author":"Schmidkonz","year":"2018","journal-title":"Prostate."},{"key":"2021051712142289000_61.1.70.17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00259-017-3657-9","article-title":"213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer","volume":"44","author":"Sathekge","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712142289000_61.1.70.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.218495"},{"key":"2021051712142289000_61.1.70.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2949-6"},{"key":"2021051712142289000_61.1.70.20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/acs.bioconjchem.7b00458","article-title":"Improving the imaging contrast of 68Ga-PSMA-11 by targeted linker design: charged spacer moieties enhance the pharmacokinetic properties","volume":"28","author":"Baranski","year":"2017","journal-title":"Bioconjug Chem."},{"key":"2021051712142289000_61.1.70.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"2021051712142289000_61.1.70.22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1682"},{"key":"2021051712142289000_61.1.70.23","doi-asserted-by":"publisher","DOI":"10.1021\/jm801055h"},{"key":"2021051712142289000_61.1.70.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1012-1"},{"key":"2021051712142289000_61.1.70.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.09.115"},{"key":"2021051712142289000_61.1.70.26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-targeting and pharmacokinetic properties of DOTA-conjugated PSMA inhibitors","volume":"59","author":"Bene\u0161ov\u00e1","year":"2016","journal-title":"J Med Chem."},{"key":"2021051712142289000_61.1.70.27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/cbr.2015.1964","article-title":"64Cu-PSMA-617 PET\/CT imaging of prostate adenocarcinoma: first in-human studies","volume":"31","author":"Grubm\u00fcller","year":"2016","journal-title":"Cancer Biother Radiopharm."},{"key":"2021051712142289000_61.1.70.28","first-page":"40","article-title":"Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer","volume":"7","author":"Cui","year":"2017","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2021051712142289000_61.1.70.29","doi-asserted-by":"publisher","DOI":"10.1021\/jm401921j"},{"key":"2021051712142289000_61.1.70.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145755"},{"key":"2021051712142289000_61.1.70.31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12325-018-0711-3","article-title":"Application of Cu-64 NODAGA-PSMA PET in prostate cancer","volume":"35","author":"Sevcenco","year":"2018","journal-title":"Adv Ther."},{"key":"2021051712142289000_61.1.70.32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11307-015-0908-7","article-title":"Targeting PSMA with a Cu-64 labeled phosphoramidate inhibitor for PET\/CT imaging of variant PSMA-expressing xenografts in mouse models of prostate cancer","volume":"18","author":"Nedrow","year":"2016","journal-title":"Mol Imaging Biol."},{"key":"2021051712142289000_61.1.70.33","first-page":"1284","article-title":"In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy","volume":"44","author":"Lewis","year":"2003","journal-title":"J Nucl Med."},{"key":"2021051712142289000_61.1.70.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2012.05.009"},{"key":"2021051712142289000_61.1.70.35","doi-asserted-by":"publisher","DOI":"10.2174\/138161207779313768"},{"key":"2021051712142289000_61.1.70.36","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/hlca.19860690832","article-title":"One-step synthesis of mono-N-substituted azamacrocycles with a carboxylic group in the side-chain and their complexes with Cu2+ and Ni2+","volume":"69","author":"Studer","year":"1986","journal-title":"Helv Chim Acta."},{"key":"2021051712142289000_61.1.70.37","doi-asserted-by":"publisher","DOI":"10.1021\/bc800039e"},{"key":"2021051712142289000_61.1.70.38","doi-asserted-by":"publisher","DOI":"10.1186\/2191-219X-2-23"},{"key":"2021051712142289000_61.1.70.39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161299"},{"key":"2021051712142289000_61.1.70.40","doi-asserted-by":"publisher","DOI":"10.1021\/ja104591m"},{"key":"2021051712142289000_61.1.70.41","first-page":"170","article-title":"[131I] MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa) [abstract]","volume":"53","author":"Hillier","year":"2012","journal-title":"J Nucl Med."},{"key":"2021051712142289000_61.1.70.42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/acs.molpharmaceut.7b00877","article-title":"Albumin-binding PSMA ligands: optimization of the tissue distribution profile","volume":"15","author":"Bene\u0161ov\u00e1","year":"2018","journal-title":"Mol Pharm."},{"key":"2021051712142289000_61.1.70.43","doi-asserted-by":"publisher","DOI":"10.1021\/jm030383m"},{"key":"2021051712142289000_61.1.70.44","doi-asserted-by":"publisher","DOI":"10.1021\/ja001295j"},{"key":"2021051712142289000_61.1.70.45","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1107\/S0108270188006365","article-title":"Structure of the barium salt of a Cu2+ complex with a tetraaza macrocyclic tetraacetate","volume":"44","author":"Riesen","year":"1988","journal-title":"Acta Crystallogr C."},{"key":"2021051712142289000_61.1.70.46","doi-asserted-by":"publisher","DOI":"10.1002\/hlca.19860690830"},{"key":"2021051712142289000_61.1.70.47","doi-asserted-by":"publisher","DOI":"10.1021\/bc00012a006"},{"key":"2021051712142289000_61.1.70.48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/ph7070779","article-title":"Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer","volume":"7","author":"Eder","year":"2014","journal-title":"Pharmaceuticals (Basel)."},{"key":"2021051712142289000_61.1.70.49","doi-asserted-by":"publisher","DOI":"10.1007\/s003350010240"},{"key":"2021051712142289000_61.1.70.50","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147181"},{"key":"2021051712142289000_61.1.70.51","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.215350"},{"key":"2021051712142289000_61.1.70.52","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.126979"},{"key":"2021051712142289000_61.1.70.53","first-page":"1649","article-title":"PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2","volume":"47","author":"Peng","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712142289000_61.1.70.54","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.195628"},{"key":"2021051712142289000_61.1.70.55","doi-asserted-by":"crossref","unstructured":"Heroux KJ Woodin KS Tranchemontagne DJ . The long and short of it: the influence of N-carboxyethyl versus N-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. Dalton Trans. 2007;2150\u20132162.","DOI":"10.1039\/b702938a"},{"key":"2021051712142289000_61.1.70.56","doi-asserted-by":"publisher","DOI":"10.1021\/jm0103817"},{"key":"2021051712142289000_61.1.70.57","doi-asserted-by":"publisher","DOI":"10.1016\/0883-2897(86)90011-5"},{"key":"2021051712142289000_61.1.70.58","first-page":"21","article-title":"Macrocyclic chelates of radiometals for diagnosis and therapy","volume":"10","author":"Meares","year":"1990","journal-title":"Br J Cancer Suppl."},{"key":"2021051712142289000_61.1.70.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(99)00049-9"},{"key":"2021051712142289000_61.1.70.60","doi-asserted-by":"publisher","DOI":"10.1021\/bc990167l"},{"key":"2021051712142289000_61.1.70.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(96)00130-8"},{"key":"2021051712142289000_61.1.70.62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jlcr.3582","article-title":"Re-thinking the role of radiometal isotopes: towards a future concept for theranostic radiopharmaceuticals","volume":"61","author":"Notni","year":"2018","journal-title":"J Labelled Comp Radiopharm."},{"key":"2021051712142289000_61.1.70.63","doi-asserted-by":"crossref","first-page":"28935","DOI":"10.18632\/oncotarget.25649","article-title":"Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts","volume":"9","author":"Yoshii","year":"2018","journal-title":"Oncotarget."},{"key":"2021051712142289000_61.1.70.64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1245\/s10434-018-6805-y","article-title":"The value of 99mTc-PSMA SPECT\/CT-guided surgery for identifying and locating lymph node metastasis in prostate cancer patients","volume":"26","author":"Su","year":"2019","journal-title":"Ann Surg Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.229054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:46:01Z","timestamp":1621284361000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.229054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,2]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.2967\/jnumed.119.229054"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.229054","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]}}}